Interferon-α associated arthritis

Journal of Rheumatology

Volumn 24, Issue 9, 1997, Pages 1844-1845

  Chung, Andrew ^a,b   Older, Steven A ^a,c  

^a BROOKE ARMY MEDICAL CENTER   (United States)

^b Department of Medicine ^*  (United States)

^c Rheumatology Service   (United States)

Author keywords

Arthritis hepatitis C; Interferon alpha

Indexed keywords

ALPHA INTERFERON; AUTOANTIBODY; HLA DR4 ANTIGEN; HYDROXYCHLOROQUINE; NONSTEROID ANTIINFLAMMATORY AGENT; RECOMBINANT ALPHA2B INTERFERON; STEROID;

ADULT; ARTICLE; AUTOIMMUNITY; CASE REPORT; DRUG WITHDRAWAL; ETIOLOGY; HEPATITIS C; HUMAN; MALE; POLYARTHRITIS; PRIORITY JOURNAL;

ADULT; ANTIVIRAL AGENTS; ARTHRITIS; AUTOANTIBODIES; CHRONIC DISEASE; HEPATITIS C; HLA-DR4 ANTIGEN; HUMANS; INTERFERON-ALPHA; MALE; RECOMBINANT PROTEINS;

EID: 0030799016     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Rubin RA, Falestiny M, Malet P: Chronic hepatitis C: Advances in diagnostic testing and therapy. Arch Intern Med 1994;154:387-92.
2. Hansen RM, Borden EC: Current status of interferons in the treatment of cancer. Oncology 1992;6:19-24.
3. Friedman RM, Vogel SN: Interferons with special emphasis on the immune system. Adv Immunol 1983;34:97-140.
4. Lovy MR, Starkebaum G, Uberoi S: Hepatitis C infection presenting with rheumatic manifestation: A mimic of rheumatoid arthritis. J Rheumatol 1996;23:979-83.
5. Ronnblom LE, Alm GV, Oberg KE: Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors. Ann Intern Med 1991;115:178-83.
6. Conlon KC, Urba WJ, Smith JW, Steis RG, Longo DL, Clark JW: Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy. Cancer 1990;65:2237-41.
7. Ferrazzi V, Jorgensen C, Sany J: Alpha-interferon therapy for leukemia or active viral hepatitis C in patients with rheumatoid arthritis (abstr). Arthritis Rheum 1994;(suppl)37:S246.
8. Chazerain P, Meyer O, Kahn M: Rheumatoid arthritis-like disease after alpha-interferon therapy (letter). Ann Intern Med 1992;116:427.
9. Ueno Y, Sohma T: Alpha-interferon-induced nodular rheumatoid arthritis in renal cell carcinoma. Ann Intern Med 1992;117:266-7.
10. Makino Y, Tanaka H, Nakamura K, Fujita M, Akiyama K, Makino I: Arthritis in a patient with psoriasis after interferon-α therapy for chronic hepatitis C. J Rheumatol 1994;21:1771-2.
11. Sztein MB, Steeg PS, Johnson HM, Oppenheim JJ: Regulation of human peripheral blood monocyte DR antigen expression in vitro by lymphokines and recombinant interferons. J Clin Invest 1984;73:556-65.
12. Schilling PJ, Kurzrock R, Kantarjian H, Gutterman JU, Talpaz M: Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemia. Cancer 1991;68:1536-7.
13. Murakami M, Iriuchijima T, Mori M: Diabetes and interferon-α therapy (letter). Ann Intern Med 1995;123:318.
14. Kim T, Kanayama Y, Negoro N, Okamura M, Takeda T, Inoue T: Serum levels of interferons in patients with systemic lupus erythematosus. Clin Exp Immunol 1987;70:562-9.
15. Hooks JJ, Moutsopoulos HM, Geis SA, Stahl NI, Decker JL, Notkins AL: Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med 1979;301:5-8.